Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11156416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stable over-expression of estrogen receptor-alpha in ECV304 cells inhibits proliferation and levels of secreted endothelin-1 and vascular endothelial growth factor.

  1999cited by this paper
• Functional role of estrogen metabolism in target cells: review and perspectives.

  1998cited by this paper
• Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.

  1996cited by this paper
• Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival.

  1996cited by this paper
• Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen.

  1996cited by this paper
• Estrogen receptor determination in endometrial carcinoma: ligand binding assay versus enzyme immunoassay.

  1995cited by this paper
• Growth regulation by estradiol, progesterone and recombinant human epidermal growth factor of human breast carcinoma xenografts grown serially in nude mice.

  1995cited by this paper
• Estrogen and progesterone receptors in malignant mixed mesodermal tumors of the ovary

  1995cited by this paper
• Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines.

  1994cited by this paper
• Adhesion molecules in cancer: the role of integrins.

  1993cited by this paper
• Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells.

  1992cited by this paper
• In situ distinction between steroid receptor binding and transactivation at a target gene

  1991cited by this paper
• Stable expression of the human estrogen receptor in HeLa cells by infection: effect of estrogen on cell proliferation and c-myc expression.

  1991cited by this paper
• Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.

  1985cited by this paper
• The effect of estrogen receptor status on survival in patients with endometrial cancer.

  1983cited by this paper
• Androgen action through estrogen receptor in a human breast cancer cell line.

  1978cited by this paper

• R Spondin in Cancer: Inducer or Impeder?

  2025cites this paper
• New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions

  2023cites this paper
• Prediction of Receptor Status in Radiomics: Recent Advances in Breast Cancer Research.

  2023cites this paper
• Roles of estrogen receptor α in endometrial carcinoma (Review)

  2023cites this paper
• Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward

  2023cites this paper
• Combat Against Gynecological Cancers with Blood Vessels as Entry Point: Anti-Angiogenic Drugs, Clinical Trials and Pre-Clinical Nano-Delivery Platforms

  2023cites this paper
• Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma

  2022cites this paper
• Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma

  2022cites this paper
• Mesenchymal-endothelial nexus in breast cancer spheroids induces vasculogenesis and local invasion in a CAM model

  2022cites this paper
• VEGF Immunoexpression in Endometrioid Endometrial Carcinomas

  2022cites this paper
• Correlation of magnetic resonance imaging quantitative parameters and apparent diffusion coefficient value with pathological breast cancer

  2022cites this paper
• Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma

  2022cites this paper
• Angiogenesis: A Pivotal Therapeutic Target in the Drug Development of Gynecologic Cancers

  2022cites this paper
• Histogram analysis of quantitative parameters from synthetic MRI: Correlations with prognostic factors and molecular subtypes in invasive ductal breast cancer.

  2021cites this paper
• The role of tumor-derived exosomes in tumor angiogenesis and tumor progression

  2019cites this paper
• ADC at 3.0 T as a noninvasive biomarker for preoperative prediction of Ki67 expression in invasive ductal carcinoma of breast.

  2018cites this paper
• Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway

  2018cites this paper
• Correlation between apparent diffusion coefficient values in breast magnetic resonance imaging and prognostic factors of breast invasive ductal carcinoma

  2018cites this paper
• Asses microvascular densities in breast ductal cell carcinoma (using CD 31 & VWF immunostain), in correlation to ER status

  2017cites this paper
• Prognostic Value of "Prepectoral Edema" in MR-mammography.

  2017cites this paper
• Role of metformin in inhibiting estrogen-induced proliferation and regulating ERα and ERβ expression in human endometrial cancer cells.

  2017cites this paper
• The Role of Angiogenesis in Cancer Treatment

  2017cites this paper
• The Effects of Estradiol and Glucocorticoid on Human Osteosarcoma Cells: Similarities and Differences.

  2016cites this paper
• Association between VEGF-A, C and D Expression and lymph Node Involvement in Breast Cancer: A Meta-Analysis

  2016influential citation
• Dysregulation of Aromatase in Breast, Endometrial, and Ovarian Cancers: An Overview of Therapeutic Strategies.

  2016cites this paper
• Effect of Allicin on Tamoxifen-sensitive MCF-7 Breast Cancer Cells

  2015cites this paper
• N-Methyl-N-nitrosourea as a mammary carcinogenic agent

  2015cites this paper
• Immunohistochemical investigation of the angiogenic proteins VEGF, HIF-1α and CD34 in invasive ductal carcinoma of the breast.

  2014cites this paper
• Intrinsic subtypes and tumor grades in breast cancer are associated with distinct 3-D power Doppler sonographic vascular features.

  2014cites this paper
• Cell cycle deregulation in breast cancer subgroups and effects on proliferation, migration and tamoxifen resistance

  2013cites this paper
• Comparative Pharmacodynamic Assessment of the Antiangiogenesis Activity of Heparin and Low-Molecular-Weight Heparin Fractions

  2013cites this paper
• Response-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate.

  2013cites this paper
• VEGF, HIF-1α Expression and MVD as an Angiogenic Network in Familial Breast Cancer

  2013cites this paper
• Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma

  2012cites this paper
• Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer

  2012cites this paper
• Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma

  2011cites this paper
• Angiogenesis Markers Quantification in Breast Cancer and Their Correlation with Clinicopathological Prognostic Variables

  2011cites this paper
• Estradiol-dependent regulation of angiopoietin expression in breast cancer cells.

  2011cites this paper
• Cell Cycle Regulatory Roles of Estrogen Receptor alpha (ERα) in Breast Cancer Cells

  2011cites this paper
• Low expression of progesterone receptor A in intermediate trophoblast of miscarriages.

  2011cites this paper
• Pomegranate sensitizes Tamoxifen action in ER-α positive breast cancer cells

  2011cites this paper
• Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer

  2010cites this paper
• Effects of cyclic versus sustained estrogen administration on peripheral immune functions in ovariectomized mice.

  2010cites this paper
• Diverse Associations between ESR1 Polymorphism and Breast Cancer Development and Progression

  2010cites this paper
• Down-regulation of C/EBPα in Breast Cancer Cells by Hypoxia-Estrogen Combination is Mainly Due to Hypoxia

  2009cites this paper
• Normal and Malignant Human Endometrium Express Immunohistochemically Estrogen Receptor Alpha ( ER-· ) , Estrogen Receptor Beta ( ER-‚ ) and Progesterone Receptor ( PR )

  2009cites this paper
• Unique ligand binding patterns between estrogen receptor alpha and beta revealed by hydrogen-deuterium exchange.

  2009cites this paper
• Correlation between steroid receptors, angiogenic factors, and classical prognostic parameters in node-negative breast cancer patients

  2009cites this paper
• Unique Ligand Binding Patterns Between Estrogen Receptor α and β Revealed by Hydrogen/Deuterium Exchange

  2009cites this paper
• Estrogen receptor and breast MR imaging features: A correlation study

  2008influential citation
• Vascular endothelial growth factor A (VEGF A) as individual prognostic factor in invasive breast carcinoma.

  2008cites this paper
• Inhibition of I Ô B kinase Ç restrains oncogenic proliferation of pancreatic cancer cells

  2008cites this paper
• Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings--preliminary results.

  2008cites this paper
• Mechanisms of estrogen sensitivity in the human endometrium

  2007cites this paper
• Inhibition of Skeletal Metastasis by Ectopic ERα Expression in ERα-Negative Human Breast Cancer Cell Lines

  2007cites this paper
• Expression and clinicopathological significance of oestrogen‐responsive ezrin–radixin–moesin‐binding phosphoprotein 50 in breast cancer

  2007cites this paper
• Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines.

  2007cites this paper
• Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.

  2007cites this paper
• International Seminars in Surgical Oncology Quantification of Angiogenesis in Estrogen Receptor-positive and Negative Breast Carcinoma

  2007cites this paper
• A new IkappaB kinase beta inhibitor prevents human breast cancer progression through negative regulation of cell cycle transition.

  2006cites this paper
• VEGF Expression is Associated with Negative Estrogen Receptor Status in Patients with Breast Cancer

  2006cites this paper
• Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity, respectively

  2006cites this paper
• Angiogenesis and capillary maturation phenotypes associated with the Edpm3 locus on rat chromosome 3

  2006cites this paper
• p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.

  2005cites this paper
• Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR).

  2005cites this paper
• Expression of Endothelial NO Synthase, Inducible NO Synthase, and Estrogen Receptors Alpha and Beta in Placental Tissue of Normal, Preeclamptic, and Intrauterine Growth-restricted Pregnancies

  2005cites this paper
• BAD is a Central Player in Cell Death and Cell Cycle Regulation in Breast Cancer Cells

  2004cites this paper
• Stromal expression of vascular endothelial growth factor correlates with tumor grade and microvessel density in mammary phyllodes tumors: a multicenter study of 185 cases.

  2004cites this paper
• Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis.

  2004cites this paper
• mRNA expression of the angiogenesis markers VEGF and CD105 (endoglin) in human breast cancer.

  2004cites this paper
• Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells.

  2004cites this paper
• Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors.

  2004cites this paper
• Expression of estrogen receptor-alpha, glucocorticoid receptor, beta-catenin and glycogen synthase kinase-3beta in the uterus of mice following long-term treatment with estrogen and glucocorticoid hormones.

  2003cites this paper
• Endometrial cancer: experimental models useful for studies on molecular aspects of endometrial cancer and carcinogenesis.

  2003cites this paper
• Correspondence re: K. Heer et al., serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. Clin. Cancer Res., 7: 3491-3494, 2001.

  2003cites this paper
• Angiogenesis Relates to Estrogen Receptor Negativity, c-erbB-2 Overexpression and Early Relapse in Node-Negative Ductal Carcinoma of the Breast

  2003cites this paper
• Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation.

  2002cites this paper
• Acceleration of invasive activity via matrix metalloproteinases by transfection of the estrogen receptor‐α gene in endometrial carcinoma cells

  2002cites this paper
• Hormonal regulation of VEGF in orthotopic MCF7 human breast cancer.

  2002cites this paper
• Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.

  2002cites this paper
• Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus.

  2001cites this paper